ELV

B of A Securities Upgrades Elevance Health (ELV)

Fintel reports that on April 29, 2026, B of A Securities upgraded their outlook for Elevance Health (NYSE:ELV) from Neutral to Buy.

Analyst Price Forecast Suggests 9.80% Upside

As of April 28, 2026, the average one-year price target for Elevance Health is $398.28/share. The forecasts range from a low of $334.31 to a high of $516.02. The average price target represents an increase of 9.80% from its latest reported closing price of $362.74 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Elevance Health is 176,691MM, a decrease of 11.84%. The projected annual non-GAAP EPS is 47.43.

What is the Fund Sentiment?

There are 1,525 funds or institutions reporting positions in Elevance Health. This is an decrease of 914 owner(s) or 37.47% in the last quarter. Average portfolio weight of all funds dedicated to ELV is 0.30%, an increase of 25.36%. Total shares owned by institutions decreased in the last three months by 12.33% to 199,799K shares. ELV / Elevance Health, Inc. Put/Call Ratios The put/call ratio of ELV is 0.60, indicating a bullish outlook.

What are Other Shareholders Doing?

Wellington Management Group Llp holds 8,290K shares representing 3.82% ownership of the company. In its prior filing, the firm reported owning 6,621K shares , representing an increase of 20.13%. The firm increased its portfolio allocation in ELV by 35.99% over the last quarter.

Price T Rowe Associates holds 7,446K shares representing 3.43% ownership of the company. In its prior filing, the firm reported owning 5,839K shares , representing an increase of 21.59%. The firm increased its portfolio allocation in ELV by 39.43% over the last quarter.

Sanders Capital holds 5,751K shares representing 2.65% ownership of the company. In its prior filing, the firm reported owning 5,769K shares , representing a decrease of 0.31%. The firm increased its portfolio allocation in ELV by 1.26% over the last quarter.

Geode Capital Management holds 5,125K shares representing 2.36% ownership of the company. In its prior filing, the firm reported owning 5,144K shares , representing a decrease of 0.38%. The firm increased its portfolio allocation in ELV by 4.65% over the last quarter.

Artisan Partners Limited Partnership holds 5,033K shares representing 2.32% ownership of the company. In its prior filing, the firm reported owning 4,577K shares , representing an increase of 9.06%. The firm increased its portfolio allocation in ELV by 25.91% over the last quarter.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.